| Trial ID: | L7029 |
| Source ID: | NCT00660998
|
| Associated Drug: |
Levitra (Vardenafil, Bay38-9456)
|
| Title: |
Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Erectile Dysfunction
|
| Interventions: |
DRUG: Levitra (Vardenafil, BAY38-9456)|DRUG: Placebo
|
| Outcome Measures: |
Primary: Sexual Encounter Profile Question 2, 12 weeks|Sexual Encounter Profile Question 3, 12 weeks | Secondary: International Index of Erectile Function - Erectile Function Domain, 12 weeks|Safety and Tolerability, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Bayer
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
318
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2003-02
|
| Completion Date: |
2004-01
|
| Results First Posted: |
|
| Last Update Posted: |
2014-12-11
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00660998
|
